Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway—A Significance for New Psychotropic Therapies
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242316840 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Renata Pukło und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Major Depressive Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Kraków, Poland, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Abstract (Originalsprache)
Recent investigations have highlighted the potential utility of the selective antagonist of the NMDA receptor GluN2B subunit for addressing major depressive disorders. Our previous study showed that the systemic administration of the antagonist of the GluN2B subunit of the NMDA receptor, the compound CP-101,606, affected liver cytochrome P450 expression and activity. To discern between the central and peripheral mechanisms of enzyme regulation, our current study aimed to explore whether the intracerebral administration of CP-101,606 could impact cytochrome P450. The injection of CP-101,606 to brain lateral ventricles (6, 15, or 30 µg/brain) exerted dose-dependent effects on liver cytochrome P450 enzymes and hypothalamic or pituitary hormones. The lowest dose led to an increase in the activity, protein, and mRNA level of CYP2C11 compared to the control. The activities of CYP2A, CYP2B, CYP2C11, CYP2C6, CYP2D, and protein levels of CYP2B, CYP2C11 were enhanced compared to the highest dose. Moreover, CP-101,606 increased the CYP1A protein level coupled with elevated CYP1A1 and CYP1A2 mRNA levels, but not activity. The antagonist decreased the pituitary somatostatin level and increased the serum growth hormone concentration after the lowest dose, while independently decreasing the serum corticosterone concentration of the dose. The findings presented here unveil a novel physiological regulatory mechanism whereby the brain glutamatergic system, via the NMDA receptor, influences liver cytochrome P450. This regulatory process appears to involve the endocrine system. These results may have practical applications in predicting alterations in cytochrome P450 activity and endogenous metabolism, and potential metabolic drug–drug interactions elicited by drugs that cross the blood–brain barrier and affect NMDA receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.
ORCID-Profile: Renata Pukło, Anna Haduch, Wojciech Kuban, Władysława A Daniel
Förderung
- National Science Center
- National Science Centre, Kraków, Poland
- Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland
Zitieren
APA
Pukło, R., Bromek, E., Haduch, A., Basińska-Ziobroń, A., Kuban, W., & Daniel, W. A. (2023). Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway—A Significance for New Psychotropic Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316840
Vancouver
Pukło R, Bromek E, Haduch A, Basińska-Ziobroń A, Kuban W, Daniel WA. Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway—A Significance for New Psychotropic Therapies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316840
BibTeX
@article{Puko2023,
author = {Pukło, Renata and Bromek, Ewa and Haduch, Anna and Basińska-Ziobroń, Agnieszka and Kuban, Wojciech and Daniel, Władysława A},
title = {Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway—A Significance for New Psychotropic Therapies},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242316840}
}
EUVIMED